Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.

Rishi, Pukhraj; Rishi, Ekta; Shroff, Daraius

Rishi, Pukhraj; Rishi, Ekta; Shroff, Daraius.

Indian J Ophthalmol ; 2009 May-Jun; 57(3): 241-2

Article in English | IMSEAR | ID: sea-70491

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Fluorescein Angiography; Humans; Injections; Male; Middle Aged; Photochemotherapy; Retinal Diseases/diagnosis; Retinal Diseases/drug therapy; Retinal Diseases/physiopathology; Retinal Neovascularization/diagnosis; Retinal Neovascularization/drug therapy; Retinal Neovascularization/physiopathology; Retinal Vessels/pathology; Telangiectasis/diagnosis; Telangiectasis/drug therapy; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Visual Acuity; Vitreous Body; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Vitreous Body

Fulltext

XML

Search on Google

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Photochemotherapy / Retinal Diseases / Retinal Vessels / Telangiectasis / Vitreous Body / Humans / Male / Fluorescein Angiography / Visual Acuity / Retinal Neovascularization Language: English Journal: Indian J Ophthalmol Year: 2009 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google